Histological assessment of the liver, and thus, liver biopsy, is a cornerstone in the evaluation and management of patients with liver disease and has long been considered to be an integral component of the clinician’s diagnostic armamentarium.
The advent of safe, well-tolerated, and highly efficacious (>95% cure rate) direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection has ushered in an era in which elimination of hepatitis C is conceivable.
Hepatic decompensation, defined by ascites, hepatic encephalopathy, and portal hypertensive gastrointestinal bleeding, is an important landmark in the natural history of cirrhosis.
The diagnosis of acute liver failure (ALF) hinges on identifying that the patient has an acute insult and is encephalopathic.
21 April 2022
21 April 2022
21 April 2022
Caitlin B. Conboy, Daniel D. Penrice, Ryan Watkins, Luis Antonio Díaz, Juan Pablo Arab, Sumera I. Ilyas – 21 April 2022
Won Sriwijitalai, Viroj Wiwanitkit – 21 April 2022